CMV-Specific Cytotoxic T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CMV-Specific Cytotoxic T Cells, covering 2013-08-26 to 2013-08-26. Get the full timeline:
Most recent: Clinical Trial Update: Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme [Phase 1, Phase 2]